RP Bio Inc. (KOSDAQ:314140)

RP Bio Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,612	14,133	3,208	16,816	6,269	7,368
Short-Term Investments	16,443	4,702	9,350	1,488	1,449	1,919
Cash & Short-Term Investments	18,055	18,836	12,558	18,304	7,718	9,286
Cash Growth	35.15%	49.99%	-31.39%	137.16%	-16.89%	-10.96%
Accounts Receivable	20,715	17,659	19,995	20,773	21,320	16,929
Other Receivables	-	38.22	353.66	332.09	112.17	70.66
Receivables	20,715	17,997	20,349	21,705	21,433	17,000
Inventory	24,293	23,962	34,109	38,590	22,569	16,389
Prepaid Expenses	-	212.71	162.67	177.36	74.56	93.5
Other Current Assets	1,937	104.95	535.72	2,266	477.83	423.35
Total Current Assets	65,000	61,112	67,714	81,043	52,272	43,192
Property, Plant & Equipment	95,977	95,921	96,975	88,727	88,970	84,991
Long-Term Investments	66.09	66.09	66.09	66.09	66.09	66.09
Other Intangible Assets	588.73	495.5	335.15	453.91	538.48	729.33
Long-Term Deferred Tax Assets	741.13	741.13	1.49	-	318.05	586.86
Other Long-Term Assets	884.74	1,133	1,096	2,798	1,573	881.91
Total Assets	163,258	159,499	166,218	173,158	143,737	130,447
Accounts Payable	23,566	17,330	20,737	29,781	24,529	15,412
Accrued Expenses	-	1,334	1,741	2,010	1,779	1,451
Short-Term Debt	21,000	25,000	25,000	34,873	36,826	39,350
Current Portion of Leases	966.25	601.39	1,007	676.85	651.95	343.22
Current Income Taxes Payable	145.89	252.07	25.14	710.76	218.3	113
Other Current Liabilities	7,393	6,658	8,986	10,579	7,385	8,542
Total Current Liabilities	53,071	51,175	57,496	78,630	71,389	65,211
Long-Term Leases	4,075	4,593	4,774	2,635	2,858	384.1
Long-Term Deferred Tax Liabilities	-	-	-	237.08	-	-
Other Long-Term Liabilities	535.8	515.29	584.61	519.18	501.27	630.13
Total Liabilities	59,693	57,196	63,471	82,021	74,748	66,323
Common Stock	4,333	4,333	4,333	4,097	3,294	3,294
Additional Paid-In Capital	65,349	65,349	65,346	58,826	37,431	37,431
Retained Earnings	33,946	32,684	33,128	28,268	24,160	20,283
Treasury Stock	-81.47	-81.47	-81.47	-81.47	-81.47	-81.47
Comprehensive Income & Other	17.88	17.88	21.56	27.33	123.52	108.95
Total Common Equity	103,565	102,303	102,747	91,137	64,927	61,035
Shareholders' Equity	103,565	102,303	102,747	91,137	68,989	64,124
Total Liabilities & Equity	163,258	159,499	166,218	173,158	143,737	130,447
Total Debt	26,041	30,194	30,781	38,185	40,336	40,078
Net Cash (Debt)	-7,986	-11,359	-18,223	-19,881	-32,618	-30,791
Net Cash Per Share	-922.84	-1313.16	-1950.62	-2791.65	-4962.17	-4629.89
Filing Date Shares Outstanding	8.65	8.65	8.65	8.18	6.57	6.57
Total Common Shares Outstanding	8.65	8.65	8.65	8.18	6.57	6.57
Working Capital	11,929	9,937	10,218	2,413	-19,117	-22,020
Book Value Per Share	11973.05	11827.16	11878.43	11145.28	9877.25	9283.22
Tangible Book Value	102,976	101,808	102,411	90,683	64,388	60,306
Tangible Book Value Per Share	11904.98	11769.88	11839.68	11089.77	9795.34	9172.30
Land	15,781	15,441	15,441	15,441	15,441	15,441
Buildings	64,175	62,866	57,487	56,367	55,187	55,187
Machinery	56,604	55,985	54,558	46,904	44,016	38,501
Construction In Progress	240.8	798	2,264	832.74	523.48	1,136

Source: S&P Global Market Intelligence. Standard template. Financial Sources.